Untreated Adult Acute Myeloid Leukemia Completed Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01101880Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative NeoplasmTreatment